{"id":"NCT00150800","sponsor":"UCB PHARMA Inc. (US)","briefTitle":"This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment","officialTitle":"An Open-label, Multi-center, Follow-up Trial to Evaluate Long Term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment at a Flexible Dose up to a Maximum of 200 mg/Day in Subjects Aged 16 Years or Older Suffering From Epilepsy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2017-09","completion":"2017-09","firstPosted":"2005-09-08","resultsPosted":"2018-12-05","lastUpdate":"2021-08-17"},"enrollment":668,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy"],"interventions":[{"type":"DRUG","name":"Brivaracetam","otherNames":[]}],"arms":[{"label":"Brivaracetam","type":"EXPERIMENTAL"}],"summary":"This trial, evaluating the long-term safety and tolerability of brivaracetam will provide subjects suffering from epilepsy, who may have benefited from brivaracetam as adjunctive treatment, the opportunity to receive open label brivaracetam treatment.","primaryOutcome":{"measure":"Percentage of Participants With at Least One Treatment-Emergent Adverse Event (TEAE) During the Study Period","timeFrame":"Visit 1 through last Evaluation Period, Down-Titration, or Post-Treatment Periods (up to 11 years)","effectByArm":[{"arm":"Brivaracetam (SS)","deltaMin":91.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":100,"countries":["United States","Australia","Brazil","Canada","India","Mexico"]},"refs":{"pmids":["32221987","34218211","26899665"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":152,"n":667},"commonTop":["Headache","Dizziness","Nasopharyngitis","Somnolence","Influenza"]}}